By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
PR Newswire CAESAREA, Israel, Sept. 27, 2024 CAESAREA, Israel, Sept. 27, 2024 /PRNewswire/ -- Nitinotes, developers of EndoZip™, a fully automated endoscopic suturing system, proudly announces the publication of their pivotal study, ...
PR Newswire AMSTERDAM, Sept. 25, 2024 A pioneering study, presented today at the EADV Congress 2024, demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS), a common and chronic skin condition, in ...
PR Newswire LEHI, Utah, Sept. 23, 2024 LEHI, Utah, Sept. 23, 2024 /PRNewswire/ -- Halia Therapeutics, Inc. (Halia), a clinical-stage biopharmaceutical company advancing novel therapies for inflammation-related diseases, today announced ...
PR Newswire HONG KONG, Sept. 17, 2024 - ASC30 is the first and only small molecule GLP-1 receptor (GLP-1R) agonist that can be dosed once-monthly subcutaneously and once-daily orally to treat obesity - ASC30 is two- to threefold more ...
PR Newswire TAMPA, Fla., Sept. 12, 2024 TAMPA, Fla., Sept. 12, 2024 /PRNewswire/ -- The Obesity Action Coalition (OAC) today responded to the Centers for Disease Control and Prevention's (CDC) newest data on obesity prevalence in the United ...
PR Newswire NEW YORK, Sept. 12, 2024 NEW YORK, Sept. 12, 2024 /PRNewswire/ -- Report with the AI impact on market trends- The global femtech devices market size is estimated to grow by USD 8.6 billion from 2024-2028, according to Technavio. ...
PR Newswire WASHINGTON, Sept. 12, 2024 Obesity Rates are Predominantly Highest in Communities Experiencing Barriers to Healthy Eating and Those with Few Opportunities for Physical Activity WASHINGTON, Sept. 12, 2024 /PRNewswire/ -- ...
PR Newswire WILMINGTON, N.C., Sept. 10, 2024 Health Food Franchise Plans Fresh Initiatives to Bring America's Youth into the Clean Eating Conversation WILMINGTON, N.C., Sept. 10, 2024 /PRNewswire/ -- The Clean Eatz Foundation, which acts ...
PR Newswire AUCKLAND, New Zealand, Sept. 10, 2024 AUCKLAND, New Zealand, Sept. 10, 2024 /PRNewswire/ -- A new study published in Obesity Pillars adds to the growing evidence behind Calocurb, a clinically proven natural GLP-1 activator ...
PR Newswire CAMBRIDGE, Mass., Sept. 4, 2024 CAMBRIDGE, Mass., Sept. 4, 2024 /PRNewswire/ -- Apnimed, Inc., a clinical-stage pharmaceutical company focused on discovery, development and commercialization of novel oral therapies for the ...
Understanding how brain chemistry and food decisions are linked to rising obesity and related health issues.
Study finds a 50% rise in overweight and obesity among adolescents in England, increasing from 22% in 2008–2010 to 33% in 2021–2023.
The increasing use of GLP-1 medications for weight loss is leading to significant changes in food preferences, with users consuming less processed foods, soda, and certain meats.
Losing a lot of weight provides long-term health benefits, even if some weight is regained.
A new study links childhood overweight and obesity to higher COPD risk, stressing early weight management for lung health.
Subscribe to our Free Newsletters!
Medindia's policies are aligned with the United Nations Sustainable Development Goals (SDGs) - SDG 3, SDG 4, SDG 5, SDG 6 , SDG 10 & SDG 12.
Disclaimer - All information and content on this site are provided for informational and educational purposes only. They should NOT be used for the diagnosis or treatment of any health-related condition or disease. Always consult a qualified healthcare professional for medical advice, diagnosis, or treatment. Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers